ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 278631 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 278631; 2) Community: the network communities that were significantly associated with the response to NSC 278631; 3) Molecule: the relationships between components within communities and NSC 278631; 4) MDR: the compounds that were significantly associated with the NSC 278631.

NSC Compound Enrichment Correlation
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0459335986102865 0.32720682
NSC 681239 Bortezomib 0.0459335986102865 0.12887493
NSC 684440 Null 0.0459335986102865 0.015553045
NSC 692228 Null 0.0459335986102865 0.084408891
NSC 697166 4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- 0.0459335986102865 -0.038162048
NSC 698058 Null 0.0459335986102865 0.38634716
NSC 702400 Null 0.0459335986102865 0.10947958
NSC 703855 Null 0.0459335986102865 0.39392837
NSC 706739 Benzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione, 2-(dimethylamino)-5-ethyl- 3b,4,5,6,7,7a,12,12b-octahydro-9-methyl- 0.0459335986102865 0.24419929
NSC 711737 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazole-2,7(1H)-dione, 4,6-dichloro-3a,7a-dihydro-, CIS- 0.0459335986102865 0.31398805
Total:92  Current:79    [First] [Prev] [Next] [Last]